Impact Analysis of Covid-19
The complete version of the Report will include the impact of the COVID-19, and anticipated change on the future outlook of the industry, by taking into the account the political, economic, social, and technological parameters.
Global Nasal Drug Delivery Systems Market, by Dosage Form (Nasal Spray, Nasal Drops, Nasal Gels, Nasal Powders, and Others), By Container Type (Non-pressurized Containers and Pressurized Containers), By System Type (Multi-dose, Bi-dose, and Unit Dose), by Therapeutics Application (Allergic and Non-allergic Rhinitis, Nasal Congestion, Vaccination, and Others), By Distribution Channel (Hospitals Pharmacies, Retail Pharmacies, and Online Pharmacies), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) is estimated to be valued at US$ 48.1 billion in 2018, and is projected to exhibit a CAGR of 6.3% over the forecast period (2018 – 2026).
Get FREE Sample PDF (Including COVID-19 Impact Analysis, Full TOC, Tables and Figures) of Nasal Drug Delivery Systems, https://www.coherentmarketinsights.com/insight/request-pdf/1944
Nasal drug delivery systems market is expected to witness fastest growth over the forecast period, owing to increasing demand from the pharmaceutical industry. Nasal drug delivery system is a transmucosal drug delivery system, where drug is administered through nasal cavity. Moreover, several studies are conducted to study the systemic bioavailability of drug and on nasal administration of vaccine, peptide and hormonal therapy, and other drugs which are usually delivered by parenteral route.
Additionally, growth of the nasal drug delivery system market is attributed to high advantages of nasal administration and rising number of innovative nasal drug delivery systems developed by market players. Moreover, expanding therapeutic application and increasing regulatory product approvals are the factors that are further expected to drive growth of the nasal drug delivery systems market over the forecast period. For instance, number of pharmaceutical and biopharmaceutical companies are adopting nasal drug delivery system for the treatment of acute migraine, pain management, Alzheimer disease, and others.
Moreover, for instance, in 2016, Lannett Company, Inc. received Abbreviated New Drug Application (ANDA) approval from the U.S. FDA for its Sumatriptan Nasal Spray intended for the treatment of migraine. Similarly, in June 2018, Impax Specialty Pharma, Inc., a specialty pharmaceutical company, received the U.S. FDA approval for Zomig Nasal Spray to treat acute migraine in patients aged 12 years and above. Furthermore, in 2017, FDA approved OptiNose U.S. Inc.’s Xhance, which is a novel combination of drug and device to deliver fluticasone propionate to treat nasal polyps.
Browse Market Data 40 Tables and 38 Figures spread through 180 Pages and in-depth TOC on “Nasal Drug Delivery Systems Market, by Dosage Form (Nasal Spray, Nasal Drops, Nasal Gels, Nasal Powders, and Others), by Container Type (Non-pressurized Containers and Pressurized Containers), by System Type (Multi Dose, Bi Dose, and Unit Dose), by Therapeutics Application (Allergic and Non-allergic Rhinitis, Nasal Congestion, Vaccination, and Others), by End User (Hospitals and Home Care Settings) and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) – Global Forecast to 2026”
To know the latest trends and insights related to nasal drug delivery systems market Press Release, click the link below: https://bit.ly/3lBmaaZ
In addition, key players in nasal drug delivery systems market are focusing on adopting inorganic strategies, in order to strengthen their position in the global market. For instance, in 2014, Endo International plc, acquired Natesto, the first and only testosterone nasal gel till that date, from Trimel BioPharma SRL, indicated for the treatment of hypogonadism via replacement therapy.
Furthermore, in 2015, Eli Lilly and Company acquired Locemia’s intranasal glucagon, which was in phase III clinical testing for the treatment of hypoglycemia. This acquisition strengthened the company’s product portfolio.
Apply Promo Code “CMIFIRST1000” And Get Instant Discount Of USD 1000
Buy Now this Premium Report to Grow your Business @ https://www.coherentmarketinsights.com/insight/buy-now/1944
Key takeaways of the Nasal Drug Delivery Systems Market:
- The global nasal drug delivery systems market is expected to exhibit a CAGR of 6.3%over the forecast period (2018-2026), attributed to increasing regulatory approvals for nasal drug delivery systems
- Among dosage form, nasal spray segment is expected to hold a dominant position in the market, owing to large number of products offered in this segment, coupled with increasing research to launch new products in this segment
- Key players operating in the global nasal drug delivery systems market include Merck & Co., GlaxoSmithKline plc, AstraZeneca plc, Johnson & Johnson, Pfizer Inc., Baxter International, Inc., Valeant Pharmaceuticals International, Inc., Becton, Dickinson and Company, and Novartis AG, among others
About Us:
Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having office at global financial capital in the U.S. and sales consultants in United Kingdom and Japan. Our client base includes players from across various business verticals in over 150 countries worldwide. We pride ourselves in catering to clients across the length and width of the horizon, from Fortune 500 enlisted companies, to not-for-profit organization, and startups looking to establish a foothold in the market. We excel in offering unmatched actionable market intelligence across various industry verticals, including chemicals and materials, healthcare, and food & beverages, consumer goods, packaging, semiconductors, software and services, Telecom, and Automotive. We offer syndicated market intelligence reports, customized research solutions, and consulting services.
To know more about us, please visit our website – www.coherentmarketinsights.com
Contact:
Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
Email: sales@coherentmarketinsights.com
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
Japan: +050-5539-1737
India: +91-848-285-0837
